Company: SCLXW
Filing Date: 2025-11-14
Form Type: 424B3
Source: 0001193125-25-283337
Chunk: 55

Company: Scilex Holding Co
Filing Date: 2025-11-14
Form: 424B3
Chunk 55
---
 shall pay to each Gloperba-Elyxyb RPA Purchaser, by wire transfer of immediately available funds in U.S. dollars to such Gloperba-Elyxyb RPA Purchaser’s account, such Gloperba-Elyxyb RPA Purchaser’s Specified Percentage (as defined in the Gloperba-Elyxyb Royalty Purchase Agreement) of the Covered Product Revenue Payments (each as defined in the Gloperba-Elyxyb Royalty Purchase Agreement) for each calendar quarter no later than 60 calendar days after the end of each calendar quarter. The Gloperba-Elyxyb Royalty Purchase Agreement shall terminate six months following receipt by the Gloperba-Elyxyb RPA Purchasers of all payments of the Gloperba-Elyxyb Purchased Receivables to which each Gloperba-Elyxyb RPA Purchaser is entitled during the Gloperba-Elyxyb Payment Term. The Company elected the fair value option for the Gloperba-Elyxyb Royalty Purchase Agreement and records the changes in the fair value within the unaudited condensed consolidated statements of operations at the end of each reporting period. As of each of February 28, 2025 and September 30, 2025, the fair value of the Gloperba-Elyxyb Royalty Purchase Agreement was $0.5 million and $1.5 million, recorded as a purchased revenue liability on the unaudited condensed consolidated balance sheet.

<div align='center'>29</div>

|                                                     | September 30, 
 2025          |       |   |
|:----------------------------------------------------|:--------------|------:|:--|
| Beginning Balance as of February 28, 2025           | $             |   500 |   |
| Repayment of purchased revenue liability            | $             |   (41 | ) |
| Change in fair value of purchased revenue liability |               | 1,041 |   |
| Ending Balance as of September 30, 2025             | $             | 1,500 |   |

8. Sorrento Stock Purchase Agreement Sorrento Stock Purchase Agreement On September 21, 2023, the Company entered into that certain Stock Purchase Agreement (the “Sorrento SPA”) with Sorrento Therapeutics, Inc. (“Sorrento”), the Company’s then-controlling stockholder, pursuant to which the Company purchased from Sorrento (i) 1,716,